FDA QSR Training & Compliance Services

FDA QSR refers to the Quality System Regulation under 21 CFR Part 820, which sets quality management requirements for medical device manufacturers. It covers how devices are designed, manufactured, documented, controlled, and monitored after release. The goal is to ensure devices are safe, effective, and consistently produced under a compliant quality system that can withstand FDA inspection.

QSR regulations cover the core elements of a medical device quality system, including management responsibility, design controls, document control, purchasing controls, production and process controls, CAPA, complaint handling, labeling, records, and internal audits. They also address training, traceability, nonconforming product, and servicing where applicable, creating a structured framework for ongoing compliance and inspection readiness.

FDA QSR training is important for medical device manufacturers, quality teams, regulatory staff, engineering teams, operations personnel, and leadership involved in quality system oversight. Anyone responsible for design controls, documentation, CAPA, complaint handling, supplier controls, or production quality should understand how Part 820 applies to their role. Effective training helps reduce errors, improve consistency, and support inspection readiness.

Most manufacturers should review QSR compliance at planned intervals through internal audits, management reviews, and targeted gap assessments, especially after major product, process, software, supplier, or organizational changes. Annual full-system reviews are common, but higher-risk or fast-growing companies may need more frequent assessments. Regular reviews help identify weaknesses early and reduce the chance of inspection observations or submission delays.

Common gaps include incomplete design history files, weak traceability between design inputs and verification, outdated procedures, inconsistent training records, poor CAPA documentation, complaint files lacking adequate investigation, and insufficient supplier controls. Companies also struggle with document control and risk management alignment. A structured assessment helps identify these issues with clear priorities so remediation can be completed before they trigger inspection findings.

Yes. Elexes supports FDA inspection readiness through internal audits, compliance assessments, documentation reviews, remediation planning, and staff training. The team helps evaluate whether procedures, records, and quality system practices align with FDA expectations, then prioritizes corrective actions. This preparation can improve response quality, reduce avoidable findings, and help teams approach inspections with stronger documentation and clearer internal accountability.

Yes. Effective FDA QSR training typically includes design controls, CAPA, document control, complaint handling, purchasing controls, production controls, and management responsibility. For many manufacturers, design controls and CAPA are especially critical because they directly affect product development, risk management, investigations, and inspection outcomes. Training should connect regulatory requirements to actual workflows, records, and responsibilities within your organization.

The timeline depends on the scope, product complexity, and maturity of your quality system. A focused assessment of selected procedures or records may take days, while a broader review of design controls, CAPA, complaints, supplier controls, and training can take several weeks. The most effective assessments include document review, gap analysis, regulatory references, and a prioritized remediation plan your team can act on immediately.